PALM CITY, Fla., Jan. 17, 2012 (GLOBE NEWSWIRE) -- GelStat Corporation (Other OTC:GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC) products for the safe and effective treatment of pain, inflammation and sleep disorders, issues a letter by its CEO to shareholders discussing accomplishments in 2011 and goals for 2012.
To Valued Shareholders and the Investment Community,
I am pleased to say that 2011 was a very productive year for GelStat. We are excited to move into 2012 and begin to reap the rewards of a solid foundation established in 2011. Here are the key accomplishments in 2011 that have prepared the Company to prosper in the coming years:
As a result, the Company is the strongest it has been since 2004 and positioned to thrive in the future. The strategy for GelStat moving forward is to become a global leader in the areas of nutraceuticals, functional beverages and other effective healthcare products. These goals will be pursued through strategic relationships with leading distribution companies worldwide, by building and leveraging a direct-to-consumer platform to launch new products, by acquiring or licensing the rights to products with proven science, by protecting its intellectual property and through organic growth of existing products. The initial goals for 2012 are as follows:
I'd like to thank all of our consultants, advisors and board members for their tireless efforts. Equally important, I would also like to thank all of our investors, shareholders, past creditors and vendors for their patience and cooperation in restructuring the Company and becoming our equity partners. Without everyone's dedication, the achievements in 2011 would not have been realized and the opportunity for GelStat in the future would not be possible.
Wishing everyone a happy, healthy and prosperous 2012!
|Gerald N. Kieft|
|Chief Executive Officer|
Make sure you are first to receive timely information on GelStat Corporation when it hits the newswire. Sign up for GelStat's email news alert system today at: http://ir.stockpr.com/gelstat/request-information
ABOUT GELSTAT CORPORATION
GelStat Corporation is dedicated to providing safe and effective over-the-counter (OTC) treatments for pain, inflammation and sleep disorders. GelStat's first two products GelStat Migraine and GelStat Sleep are sold through direct-to-consumer channels as well as in a limited number of independent retailers and pharmacies. The Company also has a suite of additional healthcare products in various stages of development that address large consumer markets. For more information, visit www.gelstat.com.
Safe Harbor Statement
This press release and the shareholder letter contains forward-looking statements including pursuing strategic relationships, building and leveraging a direct-to consumer platform to launch new products, acquiring or licensing the rights to products with proven science, growing organically and achieving each of the goals mentioned above. Forward-looking statements can be identified by words such as "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects" and similar references to future periods.
Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you therefore against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include the failure of our products to be accepted, failure to obtain partners to market and distribute our products, unanticipated delays in launching website or failure of the website to generate revenues, our inability to find a target to acquire on mutually acceptable terms, and the inability to get our reports prepared and filed timely as a result of unforeseen audit issues.
Any forward-looking statement made by us in this press release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
Gerald Kieft CEO GelStat Corporation 772-283-0020
Palm City, Florida, UNITED STATES
Gerald Kieft CEO GelStat Corporation 772-283-0020
Day's Range: 0.04-0.04
Previous Close: 0.03
Market Cap: 545,160
Day's Volume: 1,700